The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface

Journal of Virology

Volumn 86, Issue 23, 2012, Pages 12571-12581

  Yoder, Joshua D ^a   Cifuente, Javier O ^a   Pan, Jieyan ^b   Bergelson, Jeffrey M ^b,c   Hafenstein, Susan ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR; DECAY ACCELERATING FACTOR; DECAY ACCELERATING FACTOR SHORT CONSENSUS REPEAT 1; DECAY ACCELERATING FACTOR SHORT CONSENSUS REPEAT 2; DECAY ACCELERATING FACTOR SHORT CONSENSUS REPEAT 3; DECAY ACCELERATING FACTOR SHORT CONSENSUS REPEAT 4; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; CRYOELECTRON MICROSCOPY; CRYSTAL STRUCTURE; CRYSTALLIZATION; ECHO VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FOOTPRINTING; PROTEIN STRUCTURE; RHABDOMYOSARCOMA; VIRUS MORPHOLOGY; VIRUS STRAIN; X RAY CRYSTALLOGRAPHY;

ANTIGENS, CD55; CELL LINE, TUMOR; CRYOELECTRON MICROSCOPY; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; ENTEROVIRUS B, HUMAN; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; RECEPTORS, VIRUS;

ADENOVIRIDAE; COXSACKIEVIRUS;

EID: 84869209123     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01592-12     Document Type: Article

References (71)

1. Belnap DM, et al. 2000. Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus. J. Virol. 74:1342-1354.
2. Bergelson JM, et al. 1994. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. U. S. A. 91:6245-6248.
3. Bergelson JM, et al. 1995. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J. Virol. 69:1903-1906.
4. Bhella D, et al. 2004. The structure of echovirus type 12 bound to a two-domain fragment of its cellular attachment protein decayaccelerating factor (CD55). J. Biol. Chem. 279:8325-8332.
5. Brodbeck WG, Liu D, Sperry J, Mold C, Medof ME. 1996. Localization of classical and alternative pathway regulatory activity within the decayaccelerating factor. J. Immunol. 156:2528-2533.
6. Brünger AT, et al. 1998. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54:905-921.
7. Caggana M, Chan P, Ramsingh A. 1993. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J. Virol. 67:4797-4803.
8. Caspar DLD, Klug A. 1962. Physical principles in the construction of regular viruses. Cold Spring Harbor Symp. Quant. Biol. 27:1-24.
9. Chothia C. 1975. Structural invariants in protein folding. Nature 254: 304-308.
10. Cifuente JO, et al. 2011. Molecular determinants of disease in coxsackievirus B1 murine infection. J. Med. Virol. 83:1571-1581.
11. Clarkson NA, et al. 1995. Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding. J. Virol. 69:5497-5501.
12. Curry S, Chow M, Hogle JM. 1996. The poliovirus 135S particle is infectious. J. Virol. 70:7125-7131.
13. Dan M, Chantler JK. 2005. A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection. J. Virol. 79:9285-9295.
14. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66:486-501.
15. Goddard TD, Huang CC, Ferrin TE. 2007. Visualizing density maps with UCSF Chimera. J. Struct. Biol. 157:281-287.
16. Goodfellow I, et al. 2005. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors. J. Virol. 79:12016-12024.
17. Gullberg M, et al. 2010. A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells. J. Virol. 84:5868-5879.
18. Hafenstein S, et al. 2007. Interaction of decay-accelerating factor with coxsackievirus B3. J. Virol. 81:12927-12935.
19. Harvala H, Kalimo H, Bergelson J, Stanway G, Hyypia T. 2005. Tissue tropism of recombinant coxsackieviruses in an adult mouse model. J. Gen. Virol. 86:1897-1907.
20. Harvala H, et al. 2002. Mapping of tissue tropism determinants in coxsackievirus genomes. J. Gen. Virol. 83:1697-1706.
21. He Y, et al. 2001. Interaction of coxsackievirus B3 with the full-length coxsackievirus-adenovirus receptor. Nat. Struct. Biol. 8:874-878.
22. He Y, et al. 2002. Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex. Proc. Natl. Acad. Sci. U. S. A. 99:10325-10329.
23. Karnauchow TM, et al. 1996. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J. Virol. 70:5143-5152.
24. Kim MS, Racaniello VR. 2007. Enterovirus 70 receptor utilization is controlled by capsid residues that also regulate host range and cytopathogenicity. J. Virol. 81:8648-8655.
25. Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S. 1996. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J. Virol. 70:7811-7818.
26. Kolatkar PR, et al. 1999. Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor. EMBO J. 18:6249-6259.
27. Kuttner-Kondo L, et al. 2007. Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases. J. Biol. Chem. 282:18552-18562.
28. Kuttner-Kondo LA, Mitchell L, Hourcade DE, Medof ME. 2001. Characterization of the active sites in decay-accelerating factor. J. Immunol. 167:2164-2171.
29. Lee B, Richards FM. 1971. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 55:379-400.
30. Lee C, Maull E, Chapman N, Tracy S, Gauntt C. 1997. Genomic regions of coxsackievirus B3 associated with cardiovirulence. J. Med. Virol. 52: 341-347.
31. Ludtke SJ, Baldwin PR, Chiu W. 1999. EMAN: semiautomated softwar for high-resolution single-particle reconstructions. J. Struct. Biol. 128:82-97.
32. Lukacik P, et al. 2004. Complement regulation at the molecular level: the structure of decay-accelerating factor. Proc. Natl. Acad. Sci. U. S. A. 101: 1279-1284
33. Mallamo JP, et al. 1992. Conformationally restricted analogues of disoxaril: a comparison of the activity against human rhinovirus types 14 and 1A. J. Med. Chem. 35:4690-4695.
34. Medof ME, et al. 1987. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc. Natl. Acad. Sci. U. S. A. 84:2007-2011.
35. Milstone AM, et al. 2005. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J. Virol. 79:655-660.
36. Mindell JA, Grigorieff N. 2003. Accurate determination of local defocus and specimen tilt in electron microscopy. J. Struct. Biol. 142:334-347.
37. Muckelbauer JK, et al. 1995. The structure of coxsackievirus B3 at 3.5 Å resolution. Structure 3:653-667.
38. Navaza J. 1994. AMoRe: an automated package for molecular replacement. Acta Crystallogr. A 50:157-163.
39. Oliveira MA, et al. 1993. The structure of human rhinovirus 16. Structure 1:51-68.
40. Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
41. Pan J, et al. 2011. Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor. J. Virol. 85:7436-7443.
42. Pettersen EF, et al. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 24:1605-1612.
43. Pettigrew DM, et al. 2006. Structural and functional insights into the interaction of echoviruses and decay-accelerating factor. J. Biol. Chem. 281:5169-5177.
44. Pintilie GD, Zhang J, Goddard TD, Chiu W, Gossard DC. 2010. Quantitative analysis of cryo-EM density map segmentation by watershed and scale-space filtering, and fitting of structures by alignment to regions. J. Struct. Biol. 170:427-438.
45. Plevka P, et al. 2010. Interaction of decay-accelerating factor with echovirus J. Virol. 84:12665-12674.
46. Powell RM, Ward T, Evans DJ, Almond JW. 1997. Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation. J. Virol. 71:9306-9312.
47. Powell RM, Ward T, Goodfellow I, Almond JW, Evans DJ. 1999. Mapping the binding domains on decay-accelerating factor (DAF) for haemagglutinating enteroviruses: implications for evolution of a DAFbinding phenotype. J. Gen. Virol. 80:3145-3152.
48. Ramsingh A, Araki H, Bryant S, Hixson A. 1992. Identification of candidate sequences that determine virulence in coxsackievirus B4. Virus Res. 23:281-292.
49. Ramsingh AI, Collins DN. 1995. A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence. J. Virol. 69:7278-7281.
50. Reagan KJ, Goldberg B, Crowell RL. 1984. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells. J. Virol. 49: 635-640.
51. Rinehart JE, Gomez RM, Roos RP. 1997. Molecular determinants for virulence in coxsackievirus B1 infection. J. Virol. 71:3986-3991.
52. Rossmann MG, et al. 1985. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317:145-153.
53. Rossmann MG, Bernal R, Pletnev SV. 2001. Combining electron microscopic with X-ray crystallographic structures. J. Struct. Biol. 136: 190-200.
54. Shafren DR, Dorahy DJ, Ingham RA, Burns GF, Barry RD. 1997. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J. Virol. 71:4736-4743.
55. Smyth M, Pettitt T, Symonds A, Martin J. 2003. Identification of the pocket factors in a picornavirus. Arch. Virol. 148:1225-1233.
56. Stadnick E, Dan M, Sadeghi A, Chantler JK. 2004. Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3. J. Virol. 78:13987-14002.
57. Stuart AD, et al. 2002. Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping ofmutants with altered receptor requirements for infection. J. Virol. 76: 7694-7704.
58. Tam PE. 2006. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol. 19:133-146.
59. Tong LA, Rossmann MG. 1990. The locked rotation function. Acta Crystallogr. A 46:783-792.
60. Tracy S, Drescher KM. 2007. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes. Ann. N. Y. Acad. Sci. 1103:143-151.
61. Tracy S, et al. 2002. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J. Virol. 76: 12097-12111.
62. Tracy S, Gauntt C. 2008. Group B coxsackievirus virulence. Curr. Top. Microbiol. Immunol. 323:49-63.
63. Tracy S, et al. 2000. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J. Med. Virol. 62:70-81.
64. Tsueng G, et al. 2011. Coxsackievirus preferentially replicates and induces cytopathic effects in undifferentiated neural progenitor cells. J. Virol. 85:5718-5732.
65. Tu Z, et al. 1995. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5= nontranslated region. J. Virol. 69:4607-4618.
66. Tuthill TJ, Bubeck D, Rowlands DJ, Hogle JM. 2006. Characterization of early steps in the poliovirus infection process: receptor-decorated liposomes induce conversion of the virus to membrane-anchored entryintermediate particles. J. Virol. 80:172-180.
67. Uhrinova S, et al. 2003. Solution structure of a functionally active fragment of decay-accelerating factor. Proc. Natl. Acad. Sci. U. S. A. 100: 4718-4723.
68. Williams P, et al. 2003. Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 Å. J. Biol. Chem. 278:10691-10696.
69. Winn MD, et al. 2011. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67:235-242.
70. Yan X, Dryden KA, Tang J, Baker TS. 2007. Ab initio random model method facilitates 3D reconstruction of icosahedral particles. J. Struct. Biol. 157:211-225.
71. Yan X, Sinkovits RS, Baker TS. 2007. AUTO3DEM-an automated and high throughput program for image reconstruction of icosahedral particles. J. Struct. Biol. 157:73-82.